[TYPO3-UG US] IT Manager's Journal | Dana Farber turns toTYPO3and Enomaly for cancer-research site

[Reuven Cohen, Enomaly]

> I do think there is something to be learned here. This project was
> started to market T3 in the US. Why not show the article here before
> having it published? Having a few more pairs of eyes look over it can't
> hurt and makes my job easier, especially if I get emails about it later
> on. It's actually much more difficult to correct an article after it's
> been published.

We had nothing to do with the writing of this article. It's kind of hard to 
approve something that I'm aware of. Obviously if I had know they were 
publishing such erroneous information i would have corrected them before 
hand.

Reuven